Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate the drug interaction between LC15-0444 and
pioglitazone by comparing the safety, tolerability and pharmacokinetics of LC15-0444 and
pioglitazone are administered concomitantly and each alone in healthy male subjects.